Literature DB >> 16973172

Rapid assessment of the antigenic integrity of tetrameric HLA complexes by human monoclonal HLA antibodies.

Chantal Eijsink1, Michel G D Kester, Marry E I Franke, Kees L M C Franken, Mirjam H M Heemskerk, Frans H J Claas, Arend Mulder.   

Abstract

The ability of tetrameric major histocompatibility complex (MHC) class I-peptide complexes (tetramers) to detect antigen-specific T lymphocyte responses has yielded significant information about the generation of in vivo immunity in numerous antigenic systems. Here we present a novel method for rapid validation of tetrameric HLA molecules based on the presence of allodeterminants. Human monoclonal antibodies (mAbs) recognizing polymorphic determinants on HLA class I were immobilized on polystyrene microparticles and used to probe the structural integrity of tetrameric HLA class I molecules by flow cytometry. A total of 22 tetramers, based on HLA-A1, A2, A3, A24, B7 and B8 were reactive with their counterpart mAbs, thus confirming their antigenic integrity. A positive outcome of this mAb test ensures that tetrameric HLA class I can be used with greater confidence in subsequent functional assays.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16973172     DOI: 10.1016/j.jim.2006.07.020

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  4 in total

1.  Association of disparities in known minor histocompatibility antigens with relapse-free survival and graft-versus-host disease after allogeneic stem cell transplantation.

Authors:  Willemijn Hobo; Kelly Broen; Walter J F M van der Velden; Annelies Greupink-Draaisma; Niken Adisty; Yannick Wouters; Michel Kester; Hanny Fredrix; Joop H Jansen; Bert van der Reijden; J H Frederik Falkenburg; Theo de Witte; Frank Preijers; Ton Schattenberg; Ton Feuth; Nicole M Blijlevens; Nicolaas Schaap; Harry Dolstra
Journal:  Biol Blood Marrow Transplant       Date:  2012-09-27       Impact factor: 5.742

2.  Reversing endogenous alloreactive B cell GC responses with anti-CD154 or CTLA-4Ig.

Authors:  J Chen; H Yin; J Xu; Q Wang; K L Edelblum; R Sciammas; A S Chong
Journal:  Am J Transplant       Date:  2013-07-15       Impact factor: 8.086

3.  High-throughput identification of potential minor histocompatibility antigens by MHC tetramer-based screening: feasibility and limitations.

Authors:  Pleun Hombrink; Sine R Hadrup; Arne Bakker; Michel G D Kester; J H Frederik Falkenburg; Peter A von dem Borne; Ton N M Schumacher; Mirjam H M Heemskerk
Journal:  PLoS One       Date:  2011-08-05       Impact factor: 3.240

4.  Recombinant human monoclonal HLA antibodies of different IgG subclasses recognising the same epitope: Excellent tools to study differential effects of donor-specific antibodies.

Authors:  Cynthia S M Kramer; Marry E I Franke-van Dijk; Ashley J Priddey; Tamás Pongrácz; Elena Gnudi; Helena Car; Gonca E Karahan; Els van Beelen; Chalana C C Zilvold-van den Oever; Hendrik J Rademaker; Noortje de Haan; Manfred Wuhrer; Vasilis Kosmoliaptsis; Paul W H I Parren; Arend Mulder; Dave L Roelen; Frans H J Claas; Sebastiaan Heidt
Journal:  HLA       Date:  2019-08-25       Impact factor: 4.513

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.